Cutler Group’s 89bio ETNB Stock Holding History

Cutler Group’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-400	Closed	-$6K	–	3794
2023 Q3	$6K	Buy	+400	New	+$6.71K	﹤0.01%	2747
2023 Q2	–	Sell	-845	Closed	-$12K	–	3735
2023 Q1	$12K	Buy	+845	New	+$11K	﹤0.01%	2200

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Cutler Group's ETNB Position: Q4 2023 in Review

Cutler Group sold out of 89bio (ETNB) in Q4 2023, closing a stake of 400 shares — an estimated $6K sold.

Cutler Group first reported a position in ETNB in Q1 2023 and held it in 2 quarters. The position peaked at $12K in Q1 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

Cutler Group reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 400 89bio shares in Q4 2023, an estimated $6K.
Cutler Group first reported a position in 89bio in Q1 2023 and held it in 2 quarters.
Cutler Group's 89bio position peaked at $12K in Q1 2023.
153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.